Expert opinion on emerging drugs in childhood arterial ischemic stroke

Bibliography

• World Health Organization. Cerebrovascular disorders: a clinical and research classification. World Health Organisation, Geneva; 1978. p. 43
   Google Scholar
• Garner MA, Hills NK, Sidney S, The 5 years direct medical cost of neonatal and childhood stroke in a population based cohort. Neurology 2010;74:372-8
   PubMed Web of Science ®Google Scholar
• Kirkham FJ. Stroke in Children. Arch Dis Child 1999;81:85-9
   PubMed Web of Science ®Google Scholar
• Mackay MT, Witnitzer M, Benedict SL, Arterial ischemic stroke risk factors: the international pediatric stroke study. Ann Neurol 2011; In press
   Google Scholar
• Sebire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr 2004;16:617-22
   PubMed Web of Science ®Google Scholar
• Roach ES, Golomb MR, Adams R, Management of stroke in infants and children: a scientific statement form a special writing group of the American heart association stroke council and the council on cardiovascular disease in the young. Stroke 2008;39:2644-91
   PubMed Web of Science ®Google Scholar
• Paediatric stroke working group. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. Royal College of Physicians, London, UK; 2004
   Google Scholar
• Monagle P, Chalmers E, Chan A, Antithrombotic therapy in Neonates and children: American College of Chest Physicians Evidence – Based Clinical Practice Guidelines. 8th edition. Chest 2008;133:887S-989S
   PubMed Web of Science ®Google Scholar
• Faustino EV, Apkon M. Persistent hyperglycaemia in critically ill children. J Paediatr 2005;146:30-4
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Spinella PC, Drott HR, Association of timing, duration and intensity of hyperglycaemia with intensive care mortality in critically ill children. Pediatr Crit Care Med 2004;5:329-36
   PubMedGoogle Scholar
• Reith J, Jorgenson HS, Pederson PM, Body temperature in acute strokes: relation to stroke severity, infarct size, mortality and outcome. Lancet 1996;347:422-5
   PubMed Web of Science ®Google Scholar
• Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000;31:410-14
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, del Zoppo G, Alberts MJ, Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Interventional Council and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Circulation 2007;115:e478-534
   PubMed Web of Science ®Google Scholar
• Azzopardi D, Strohm B, Edwards AD, Moderate hypothermia to treat perinatal asphyxial encephalopathy. New Eng J Med 2009;361(14):1349-58
   PubMed Web of Science ®Google Scholar
• Castillo J, Leira R, Garcia MM, Blood pressure decrease during the acute phase of ischaemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35:520-46
   PubMed Web of Science ®Google Scholar
• deVeber G. Stroke and the Child's Brain: an overview of epidemiology, syndromes and risk factors. Curr Opin Neurol 2002;15:133-8
   PubMed Web of Science ®Google Scholar
• Mallick A, O'Callaghan FJK. The epidemiology of childhood stroke. Eur J Paediatr Neurol 2010;14:197-205
   PubMed Web of Science ®Google Scholar
• Strater R, Becker S, Von Eckardstein A, Prospective assessment of risk factors for recurrent stroke during childhood. Lancet 2002;360:1540-5
   PubMed Web of Science ®Google Scholar
• Ganesan V, Prengler M, Wade A, Clinical and radiological recurrence after childhood arterial ischaemic stroke. Circulation 2006;114:2170-7
   PubMed Web of Science ®Google Scholar
• Chabrier S, Husson B, Lasjaunias P, Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 2000;15:290-4
   PubMed Web of Science ®Google Scholar
• Garner MA, Hills NK, Sidney S, The 5 years direct medical cost of neonatal and childhood stroke in a population based cohort. Neurology 2010;74:372-8
   PubMed Web of Science ®Google Scholar
• deVeber G. In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guideline. Lancet Neurol 2005;4(7):432-6
   PubMed Web of Science ®Google Scholar
• Smith SE, Fj Kirkham, G DeVeber, Outcome following decompressive craniotomy for malignant middle cerebral artery infarction in children. Dev Med Child Neurol 2001;53(1):29-33
   Google Scholar
• Hacke W, Kaste M, Fieschi C, Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke study (ECASS). JAMA 1995;274:1017-25
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for acute ischaemic stroke. The National Institute of Neurological disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7
   PubMedGoogle Scholar
• Clark WM, Wissman S, Albers GW, Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282:2019-26
   PubMed Web of Science ®Google Scholar
• Monagle P, Barnes C, Ignjatovic VA, Developmental hemostasis laboratories. Thromb Haemost 2006;95:362-72
   PubMed Web of Science ®Google Scholar
• Barnes C, deVeber G. Prothrombostic abnormalities in childhood ischemic stroke. Thromb Res 2006;118:67-74
   PubMed Web of Science ®Google Scholar
• Gabis LV, Yangala R, Lenn NJ. Time lag to diagnosis of stroke in children. Pediatrics 2002;110:924-28
   PubMed Web of Science ®Google Scholar
• McGlennan C, Ganesan V. Delays in investigation and management of acute arterial ischaemia stroke in children. Dev Med Child Neurol 2008;50:537-40
   PubMed Web of Science ®Google Scholar
• Mubeen F, Rafay MF, Pontigon AM, Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke 2009;40:58-64
   PubMed Web of Science ®Google Scholar
• Hartman AL, Lunney KM, Serena JE. Pediatric stroke: do clinical factors predict delays in presentation? J Pediatr 2009;154(5):727-32
   PubMed Web of Science ®Google Scholar
• Srinivasan J, Miller SP, Thanh G, Delayed Recognition of Initial Stroke in children: need for increased awareness. Pediatrics 2009;124(2):e227-34
   PubMed Web of Science ®Google Scholar
• Amlie- Lefond C, Chan AK, Kirton A, Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial. Neuroepidemiology 2009;32:279-86
   PubMed Web of Science ®Google Scholar
• Janjua N, Nasae A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide sample. Stroke 2007;38:1850-4
   PubMed Web of Science ®Google Scholar
• Gupta AA, Leaker M, Andrew M, Safety outcome of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001;139:682-88
   PubMed Web of Science ®Google Scholar
• Tsigoulis G, Horton JA, Ness JM, Intravenous thrombolysis followed by intra-arterial thrombolysis and mechanical thrombectomy for the treatment of pediatric ischemic stroke. J Neurol Sci 2008;275:151-3
   PubMed Web of Science ®Google Scholar
• Belvis R. Thrombolysis for acute stroke in pediatrics. Stroke 2007;38:1722-32
   PubMed Web of Science ®Google Scholar
• Benedict SL, Ni OK, Schloesser P, Intra-arterial thrombolysis 2-year-old with cardioembolic stroke. J Child Neurol 2007;22:225-7
   Google Scholar
• Wahlgreen N, Ahmed N, Dalavos A, Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of thrombolysis in stroke monitoring study (SITS- MOST): an observational study. Lancet 2007;369:275-82
   PubMed Web of Science ®Google Scholar
• Arnold M, Steinlin M, Baumann A, Thrombolysis in childhood stroke. Report of 2 cases and review of the literature. Stroke 2009;40:801-7
   PubMed Web of Science ®Google Scholar
• Amlie- Lefond C, deVeber G, Chan VK, Use of alteplase in childhood arterial ischemic stroke: a multicentre, observational, cohort study. Lancet Neurol 2009;8:530-36
   PubMed Web of Science ®Google Scholar
• Kirkham FJ, DeBaun MR. Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004;6:357-75
   PubMedGoogle Scholar
• Adams RJ, McKie VC, Hsu L, Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonagraphy. N Engl J Med 1998;339:5-11
   PubMed Web of Science ®Google Scholar
• Lee MT, Piomelli S, Granger S. Stroke Prevention trial in sickle cell anemia (STOP): extended follow-up and the final results. Blood 2006;108(3):847-52
   PubMed Web of Science ®Google Scholar
• Adams RJ, Brambillia D. Discontinuing prophylactic transfusions used to prevent sickle cell disease. The optimizing primary stroke prevention in sickle cell anemia (STOP 2) Trial Investigators. N Engl J Med 2005;353:2769-78
   PubMed Web of Science ®Google Scholar
• Yarbro JW. Mechanism of action of hydroxyurea. Semin Oncol 1992;19(Suppl 9):1-10
   PubMed Web of Science ®Google Scholar
• Hofrichter J, Ross PD, Eaton WA. Kinetics and mechanisms of deoxyhaemoglobin S gelation: a new approach to understanding sickle cell disease. Proc Natal Acad Sci USA 1974;71:4864-8
   PubMed Web of Science ®Google Scholar
• Zimmerman SA, Schultz WH, Burgett S, Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anaemia. Blood 2007;110:1043-7
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute (NHLBI). Stroke with transfusions changing to hydroxyurea (SWiTCH). Clinical Trials. Gov. NCT00122980
   Google Scholar
• Antenatal and Newborn Screening Programs: Sickle cell disease in childhood in the UK. Published by Sickle Cell Society.2208. Available from: www.sicklecellsociety.org
   Google Scholar
• Gubitz G, Sandercock P, Counsell C. Anticoagulation for acute ischaemic stroke. Cochrane Database Syst Rev 2004;3:CD000024
   PubMedGoogle Scholar
• Braun KPJ, Bulder MMM, Chabrier S, The course and outcome of unilateral intracranial arteriopathy in 79children with ischaemic stroke. Brain 2009;132:544-57
   PubMed Web of Science ®Google Scholar
• Danchaivijtr N, Cox T, Saunders DE, Evolution of cerebral arteriopathies in childhood ischaemic stroke. Ann Neurol 2006;59:620-6
   PubMed Web of Science ®Google Scholar
• Lanthier S, Armstrong D, Domi T, Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology 2005;64(4):660-3
   PubMed Web of Science ®Google Scholar
• Monagle P, Chan A, Massicotte P, Antithrombotic therapy in children: the seventh ACCP Conference on Antithrombotic and Thrombolytic therapy. Chest 2004;126:645S-87S
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Dichiara J, Evaluation of dose related effects of aspirin on platelet function: results from the Aspirin Induced Platelet Effect (ASPECT) study. Circulation 2007;115:3156-64
   PubMed Web of Science ®Google Scholar
• Chen ZM, Sandercock P, Pan HC, Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomised patients from the Chinese acute stroke trial and the international stroke trial. On behalf of CAST and IST collaborative groups. Stroke 2000;31:1240-9
   PubMed Web of Science ®Google Scholar
• CAST: randomized placebo- controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative group. Lancet 1999;349:1641-9
   Web of Science ®Google Scholar
• Mohr JP, Thompson JL, Lazar RM, A comparison of warfarin and aspirin for prevention of recurrent ischaemic stroke. N Engl J Med 2001;345:1444-51
   PubMed Web of Science ®Google Scholar
• Belvis R, Pagonabarraga J, Santamaria A, Kulisevsky J. Clopidegrel in secondary ischaemic stroke prevention. Recent Pat Cardiovasc Drug Discov 2008;3:119-25
   PubMedGoogle Scholar
• Mandava P, Thiagarajan P, Kent TA. Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions. Drugs 2008;68:1019-28
   PubMed Web of Science ®Google Scholar
• Soman T, Rafay MF, Hune S, The risks and safety of clopidegrel in pediatric arterial ischaemic stroke. Stroke 2006;37:1120-2
   PubMed Web of Science ®Google Scholar
• Andrew M, Marzinotto V, Massicotte P, Heparin and low-molecular–weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest 2001;119:S64-94
   PubMed Web of Science ®Google Scholar
• Strater R, Kurnik K, Heller C, Aspirin versus low dose low molecular weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow up study. Stroke 2001;32:2554-8
   PubMed Web of Science ®Google Scholar
• Bernard TJ, Goldenburg NA, Tripputi M, Anticoagulation in childhood – onset arterial ischemic stroke with non moyamoya arteriopathy. Findings from the Colorado and German (COAG) Collaboration. Stroke 2009;40:2869-71
   PubMed Web of Science ®Google Scholar
• Ansell J, Hirsch J, Poller L, The pharmacology and management of vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:204S-33S
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, RE-LY Steering committee and investigators. Dagibatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:11139-1151
   Web of Science ®Google Scholar
• Benseler SM, Silverman ED, Aviv RL, Primary central nervous system vasculitis in children. Arthritis Rheum 2006;53:1291-7
   Web of Science ®Google Scholar
• Soon GS, Yau I, Branson H, Nonprogressive primary CNS vasculitis in children: imunosuppression reduces the recurrent ischaemic events. Arthritis Rheum 2006;33:2078-80
   Google Scholar
• Riou EM, Amlie – Lefond C, Echenne B, Cerebral Spinal fluid analysis in the diagnosis and treatment of arterial ischemic stroke. Pediatr Neurol 2008;38:1-9
   PubMed Web of Science ®Google Scholar
• Aviv RL, Beneseler SM, deVeber G, Angiography of primary central nervous system angiitis of childhood: conventional angiography versus magnetic resonance angiography at presentation. Am J Neuroradiol 2006;27:192-9
   PubMed Web of Science ®Google Scholar
• Eleftheriou D, Cox T, Saunders D, Investigations of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography at presentation. Dev Med Child Neurol 2010;52(9):863-7
   PubMed Web of Science ®Google Scholar
• Lanthier S, Lortie A, Michaud J, Isolated angiitis of the CNS in children. Neurology 2001;56:837-42
   PubMed Web of Science ®Google Scholar
• Britter KJ, Epstein LG, Melin-Aldana H, Cyclophosphamide treatment of primary angiitis of the central nervous system in children: report of 2 cases. J Rheumatol 2006;33:2078-80
   PubMed Web of Science ®Google Scholar
• Sen ES, Leone V, Abinun M, Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil. Dev Med Child Neurol 2010;52:1033-7
   PubMed Web of Science ®Google Scholar
• Hutchison C, Elbers J, Halliday W, Treatment of small vessel primary CNS vasculitis in children: an open label cohort study. Lancet Neurol 2010;9:1078-84
   PubMed Web of Science ®Google Scholar
• Cellucci T, Benseler SM. Central nervous system vasculitis in children. Curr Opin Rheumatol 2010;22:590-7
   PubMed Web of Science ®Google Scholar
• Eleftheriou D, Ganesan V. Controversies in childhood arterial ischemic stroke and cerebral venous sinus thrombosis. Expert Rev Cardiovasc Ther 2009;7(7):853-61
   PubMedGoogle Scholar
• Wraige E, Pohl KR, Ganesan V. A proposed classification for subtypes of arterial ischaemic stroke in children. Dev Med Child Neurol 2005;47(4):252-6
   PubMed Web of Science ®Google Scholar
• Eleftheriou D, Clarke LA, Hong Y, Circulating endothelia cells and endothelial progenitor cells in childhood primary angiitis of the central nervous system. Pediatr Rheumat 2008;69(Suppl 1):278
   Google Scholar
• Amlie-Lefond C, Bernard TJ, Sebire G, Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 2009;119(10):1417-23
   PubMed Web of Science ®Google Scholar
• Bernard TJ, Fenton LZ, Apkon SD, Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr 2010;156(4):651-6
   PubMed Web of Science ®Google Scholar
• Buerki S, Roellin K, Remonda L, Neuroimaging in childhood arterial ischaemic stroke; evaluation of imaging modalities and aetiologies. Dev Med Child Neurol 2010;52(11):1033-7
   PubMed Web of Science ®Google Scholar
• Guo DC, Papke CL, Tran-Fadulu V, Mutations in smooth muscle alph-actin (ACTA2) cause coronary artery diseasem stroke and moyamoya disease along with thoracic aortic disease. Am J Hum Genet 2009;84:617-27
   PubMed Web of Science ®Google Scholar
• Amarenco P, Goldstein LB, Szarek M, Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attach: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke 2007;38:198-204
   PubMed Web of Science ®Google Scholar
• Nassief A, Narsh JD. Statin therapy for stroke prevention. Stroke 2008;39:1042-8
   PubMed Web of Science ®Google Scholar
• Lasater EA, Bessler WA, Mead LE, Nf1+/− mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Hum Mol Genet 2008;17(15):2336-44
   PubMed Web of Science ®Google Scholar